Progress Note:   Subjective:  In to check patient. Patient still c/o HA.  Objective:  Vitals:   [**DATE**] 0539 [**DATE**] 0554 [**DATE**] 0639 [**DATE**] 0654  BP: (!) 153/91 (!) 158/91 141/90 150/86  Pulse:      Resp:      Temp:      TempSrc:      SpO2:      Weight:      Height:        Recent Labs Lab [**DATE**] 1843 [**DATE**] 0540 [**DATE**] 1800 [**DATE**] 2310 [**DATE**] 1130 [**DATE**] 2034 [**DATE**] 0630  WBC 14.1* 16.6* 18.1* 16.7* 17.3* 15.0* 13.5*  HGB 9.0* 8.9* 8.8* 8.3* 9.5* 9.8* 9.3*  HCT 30.0* 29.3* 28.3* 27.2* 32.7* 31.8* 29.4*  PLATCOUNT 313 313 312 275 270 321 272  BUN 5* 4* 5* 4*  --  6  --   CREATININE 0.57 0.47 0.52 0.52  --  0.55  --   TPROT 6.6 6.5 6.5 6.2*  --  7.1  --   ALB 3.5 3.0* 3.1* 2.8*  --  3.2*  --   AST 11 10 9 12  --  15  --   ALT 7 6 7 7  --  10  --   TBILI <0.1 <0.1 0.1 <0.1  --  <0.1  --   DBILI <0.2 <0.2 <0.2 <0.2  --  <0.2  --   MG 4.8* 4.4* 4.2* 4.3*  --  4.7*  --   URICACID 5.7 5.0 4.8 4.6  --  5.0  --      FHT:125, min-moderate variability, late appearing decel at 0544 -> repositioning  TOCO: Quiet CVX: [**DATE**], unchanged    Assessment: 24 y.o. G4P3003 at 27w6d who presented [**DATE**] with severe preeclampsia.  -Severe Preeclampsia: treated on admission with 20,40,40 IV Labetalol and 300 PO Labetalol TID - Patient with severe range pressures in the 170s/100s (last severe range pressure at 2145 on [**DATE**]). Treated with labetalol 20, 20, 40 and hydralazine 10. Patient currently with mild range pressures after treatment.  Plan:  1. CTM Blood pressures closely. Continue Magnesium Sulfate at this time. Continue Labetalol 300 mg TID 2. CTM s/s of preeclampsia and patient instructed to notify team if symptoms worsen. 3. CEFM 4. S/p BMS @ 2200 ([**DATE**])  5. Continue IOL for severe preeclampsia. Foley in at [**DATE**]; increase pitocin per protocol, currently at 16   [**NAME**], MD 7:13 AM [**DATE**] 